Literature DB >> 8528300

Functional electromyostimulation of the corpus cavernosum penis--preliminary results of a novel therapeutic option for erectile dysfunction.

C G Stief1, E Weller, T Noack, M Djamilian, M Meschi, M Truss, U Jonas.   

Abstract

Transcutaneous application of low-frequency electric current in the treatment of partially or temporarily denervated striated muscles is widely used to prevent or treat muscular atrophy. Due to the high regenerative capacity of smooth-muscle cells, this approach should be beneficial in the treatment of diseases with smooth-muscle degeneration due to partial denervation. Our study was done to evaluate the possible beneficial effect of transcutaneously applied low-frequency electric current on the corpus cavernosum penis in the treatment of erectile dysfunction. After a comprehensive workup, 21 patients with chronic erectile dysfunction (20/21 vasoactive nonresponders) received daily (3-5 x 20 min) transcutaneous functional electromyostimulation of the corpus cavernosum smooth muscles [FEMCC; zero-line symmetric impulses of trapezoid shape, 2-channel device with alternating stimulations; frequency (f), 10-20 Hz for channel I and 20-35 Hz for channel II; impulse duration (ti), 100-150 microseconds; approx. 12 mA; rise time, 0.5 s; stimulation time, 5 s/channel; pause between stimulations, 0.5 s. In all, 4/21 patients (19%) regained full spontaneous erections and another 3/21 (14%) responded to vasoactive drugs after FEMCC. Overall, 14/21 were FEMCC failures, including 2 who subjectively "improved." In a similar group of patients who were evaluated during the same period but received no therapy, no spontaneous improvement in erectile function was observed.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 8528300     DOI: 10.1007/bf00182971

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  25 in total

1.  Penile vein ligation for corporeal incompetence: an evaluation of short-term and long-term results.

Authors:  B Rossman; M Mieza; A Melman
Journal:  J Urol       Date:  1990-09       Impact factor: 7.450

2.  Intracavernous injection of prostaglandin E1 for the treatment of erectile impotence.

Authors:  N Ishii; H Watanabe; C Irisawa; Y Kikuchi; Y Kubota; S Kawamura; K Suzuki; R Chiba; M Tokiwa; M Shirai
Journal:  J Urol       Date:  1989-02       Impact factor: 7.450

3.  Auto-injection of the corpus cavernosum with a vasoactive drug combination for vasculogenic impotence.

Authors:  A W Zorgniotti; R S Lefleur
Journal:  J Urol       Date:  1985-01       Impact factor: 7.450

4.  Penile venous surgery.

Authors:  T F Lue
Journal:  Urol Clin North Am       Date:  1989-08       Impact factor: 2.241

5.  Management of erectile impotence. Use of implantable inflatable prosthesis.

Authors:  F B Scott; W E Bradley; G W Timm
Journal:  Urology       Date:  1973-07       Impact factor: 2.649

6.  Physiology of erection and pharmacological management of impotence.

Authors:  T F Lue; E A Tanagho
Journal:  J Urol       Date:  1987-05       Impact factor: 7.450

7.  Intracavernous injection of papaverine for erectile failure.

Authors:  R Virag
Journal:  Lancet       Date:  1982-10-23       Impact factor: 79.321

8.  Long-term results of penile vein ligation for impotence from venous leakage.

Authors:  A L Freedman; F Costa Neto; C M Mehringer; J Rajfer
Journal:  J Urol       Date:  1993-05       Impact factor: 7.450

9.  Followup results of a combination of calcitonin gene-related peptide and prostaglandin E1 in the treatment of erectile dysfunction.

Authors:  M Djamilian; C G Stief; M Kuczyk; U Jonas
Journal:  J Urol       Date:  1993-05       Impact factor: 7.450

10.  Prognostic factors for the postoperative outcome of penile venous surgery for venogenic erectile dysfunction.

Authors:  C G Stief; M Djamilian; M C Truss; H Tan; W F Thon; U Jonas
Journal:  J Urol       Date:  1994-04       Impact factor: 7.450

View more
  2 in total

1.  Erectile function outcomes in the current era of anatomic nerve-sparing radical prostatectomy.

Authors:  Arthur L Burnett
Journal:  Rev Urol       Date:  2006

Review 2.  Prostatic irradiation-induced sexual dysfunction: A review and multidisciplinary guide to management in the radical radiotherapy era (Part II on Urological Management).

Authors:  Marc J Rogers; Marigdalia K Ramirez-Fort; James A Kashanian; Seth A Broster; Jaime Matta; Sean S Mahase; Digna V Fort; M Junaid Niaz; Shearwood McClelland; Neil H Bander; Migdalia Fort; Christopher S Lange; Peter Schlegel; John P Mulhall
Journal:  Rep Pract Oncol Radiother       Date:  2020-05-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.